Retrophin (RTRX) Reports Q2 Loss of $0.52

Retrophin (NASDAQ: RTRX) reported Q2 EPS of ($0.52), versus ($0.21) reported last year. Revenue for the quarter came in at $5.74 million, versus $0 reported last year.Retrophin reaffirmed FY2014 guidance.

For earnings history and earnings-related data on Retrophin (RTRX) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Cosmos Health posts 29% revenue rise in Q2 but net loss widens